Is Ataxia Commonly Misdiagnosed as Parkinson's Disease?

Yes, being initially misdiagnosed with Parkinson’s disease before receiving a diagnosis of autosomal dominant cerebellar ataxia (ADCA) is a well-known challenge. In the early stages, certain forms of spinocerebellar ataxia (SCA)—which are the specific genetic conditions that fall under the ADCA umbrella—can look identical to Parkinson’s disease, leading to a long and frustrating diagnostic journey for many patients ^[1][2].

Why Misdiagnoses Happen

Spinocerebellar ataxias and Parkinson’s disease are both neurological movement disorders, and their symptoms can heavily overlap. Many patients with specific types of ataxia initially present with parkinsonism, a group of neurological symptoms that includes:

• Tremors (involuntary shaking)
• Rigidity (muscle stiffness)
• Bradykinesia (slowness of movement)

Because these are the hallmark signs of Parkinson’s disease, doctors often make that diagnosis first ^[3][4]. Compounding the confusion, some ataxia patients will even respond well to levodopa (the standard medication for Parkinson’s disease) in the beginning ^[1]. Over time, however, this medication may stop working or cause significant involuntary movements (dyskinesias), which often prompts doctors to re-evaluate the diagnosis ^[2].

A crucial clue for doctors is often your family history. Because SCAs are inherited, a family tree showing multiple generations with diagnoses of “Parkinson’s,” “ALS,” or general “balance issues” strongly points a neurologist toward an inherited ataxia rather than sporadic Parkinson’s disease ^[5].

The “Great Mimics”: SCA2 and SCA3

While many ataxias share symptoms with other conditions, two specific subtypes—SCA2 and SCA3 (and sometimes rarer forms like SCA17)—are notorious for mimicking other neurodegenerative diseases.

Spinocerebellar Ataxia Type 2 (SCA2)

SCA2 can sometimes present almost entirely as a parkinsonian syndrome, even without the balance and coordination issues normally expected ^[6][7]. Additionally, there is a genetic link between the ATXN2 gene (which causes SCA2) and Amyotrophic Lateral Sclerosis (ALS). While large mutations in this gene cause SCA2, “intermediate-length” mutations increase the risk of ALS ^[8]. Because of this genetic overlap, these conditions are sometimes grouped under the broader term “ATXN2-related neurodegeneration” ^[8], and patients can be misdiagnosed with ALS before their genetics are clarified ^[9].

Spinocerebellar Ataxia Type 3 (SCA3)

Also known as Machado-Joseph Disease, SCA3 is the most common dominantly inherited ataxia. Some patients, particularly those who develop symptoms at a younger age, show prominent parkinsonian features like facial grimacing and rigidity before any typical ataxia symptoms appear ^[10][11]. SCA3 can also be mistaken for Multiple System Atrophy (MSA-C) due to shared cerebellar features ^[12].

How Genetic Testing Clarifies the Diagnosis

Because clinical exams and even brain scans cannot reliably tell the difference between these conditions in their early stages ^[13], targeted genetic testing is critical ^[5].

A blood or saliva test looks directly at your DNA for specific gene expansions—which you can think of as a “stutter” or repeating error in your DNA code—that cause SCA2, SCA3, and other forms of ataxia. Finding the exact genetic mutation provides a definitive answer ^[14][15].

However, genetic testing for a progressive, inherited disease carries heavy emotional and familial implications. It is highly recommended to undergo genetic counseling before testing. A genetic counselor will help you understand the emotional impact, the risks to family members, and the insurance implications.

Adjusting to Your New Diagnosis

Receiving a revised diagnosis can carry a heavy emotional toll. It is normal to feel grief or anxiety when moving from a Parkinson’s diagnosis, which has many well-known symptomatic treatments, to a rarer condition like ataxia.

Getting the correct diagnosis allows you and your care team to safely transition away from unhelpful medications, properly anticipate future symptoms, and connect with the right clinical trials and support networks ^[16]. While ataxia therapies are different from Parkinson’s treatments, there is still much that can be done. Your care team will focus on targeted symptom management, specialized physical and occupational therapy, and improving your overall quality of life ^[16].